Evidence of hepatitis in patients receiving transfusions of blood components containing antibody to hepatitis C.
نویسندگان
چکیده
When hepatitis C virus antibody (anti-HCV) enzyme immunoassay (EIA1) testing became available in 1990, we tested samples from previously transfused blood units, traced the recipients of reactive units, and evaluated the recipients for HCV infection during the 12 months after transfusion. Ten of 42 recipients of EIA1-reactive blood were anti-HCV reactive on follow-up by EIA1 and 12 were reactive by a second-generation assay (EIA2). Reverse transcriptase-polymerase chain reaction (RT-PCR) detected HCV RNA in 5 seronegative recipients. In all, 17 of 42 recipients (40%) of EIA1-reactive blood had evidence of HCV infection. In comparison, 54 surgery patients, who received either no transfusion or autologous EIA1-nonreactive blood, remained EIA1 nonreactive and RT-PCR negative for 1 year; 1 patient (1.8%) became EIA2 reactive (P < or = .01). Of the recipients of anti-HVC reactive blood transfusions (reactive by both EIA1 and a supplemental 4-antigen strip immunoblot assay [RIBA2]), 14 (93%) of the recipients had evidence of HCV infection compared with only 3 of 27 recipients (11%) of EIA1-reactive, RIBA2-nonreactive blood (P < or = .01). Thus, blood components reactive for anti-HCV EIA1 may have transmitted HCV up to 40% of the time, but blood components found reactive by both EIA1 and RIBA2 may transmit HCV with a frequency of greater than 90%.
منابع مشابه
The Prevalence of Blood-Borne Viral Infection (HBV, HCV, HIV) among Hemophilia Patients in Hamedan Province of Iran
Background: Hemophilia A and B are the most frequent congenital coagulation disorders. This study was conducted to determine the prevalence of hepatitis B, C and human immunodeficiency viruses among hemophilic patients in Hamadan, Iran. Patients and Methods: In this study, patients with hemophilia A and B treated in Hamedan Hemophilia Center, Hamedan, Iran, were screened for hepatitis B, C and...
متن کاملPrevalence of hepatitis C resulted from blood transfusion in major thalassemia patients in Semnan, Damghan and Garmsar (2002)
Introduction: Hepatitis C is one of the most important liver diseases in the world. The most common cause of hepatitis is blood transfusion. Children with thalassemia who receive frequent blood transfusions are at high risk of hepatitis C virus (HCV) infection. Thus their diagnosis and treatment on them causes reduction of next consequences. Methods: In this descriptive study all the pat...
متن کاملDetermination of Hepatitis B Surface Antibody Titer in Vaccinated Children with Major Thalassemia in Kerman-Iran
Background: Thalassemia patients are more susceptible to hepatitis than the normal population due to the frequent blood transfusions. Objective: To determine the immune response of children with major ß-thalassemia, by measuring anti-hepatitis B surface antibody (anti-HBs Ab) following the last HBV vaccine injection. Methods: This study was carried out on 215 thalassemic children who received t...
متن کاملThe Urgency to Mitigate the Spread of Hepatitis C in Pakistan Through Blood Transfusion Reform
Blood transfusions are contributing to a higher rate of hepatitis C virus (HCV) in Pakistan. Half of all blood transfusions in Pakistan are not screened for hepatitis C, hepatitis B or HIV. Family members donate blood that is likely not tested due to social stigma attached to HCV. Paid donations are also quite common in the country, especially by people who inject drugs (PWID), which increases ...
متن کاملVertical transmission of hepatitis C from pregnant - mothers to their
Introduction: Besides from dermal route, recently vertical transmission of hepatitis C has been a matter of investigation and the risk of transmission is evaluated. The aim of this study was to determine the risk of mother-to-infant vertical transmission of hepatitis C. Methods: In this descriptive study, over a period of 2 years, between Aug. 1998 and Jun. 2000, two thousands pregnant women ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Blood
دوره 82 3 شماره
صفحات -
تاریخ انتشار 1993